文献速递乳腺US乳腺X线

添加超声造影可提高乳腺常规超声和钼靶对活检证实导管原位癌病理升级的预测能力

Adding contrast-enhanced ultrasound can improve the predictive ability of breast conventional ultrasound and mammography for pathological upgrade of biopsy-confirmed ductal carcinoma in situ.
PubMed 文献 · Eur J Radiol · 2024-08-20

本回顾性研究纳入138例患者的140个活检证实导管原位癌病灶,比较术后病理升级组与未升级组的常规超声、钼靶、超声造影及临床病理特征。59个(42.1%)病灶术后升级为浸润癌;超声造影特征(灌注缺损、TIC>1021.34 ml面积)为独立预测因素,加入超声造影后模型AUROC由0.759升至0.861(P=0.018)。

要点

  • 活检证实导管原位癌中42.1%(59/140)术后升级为浸润癌。
  • 超声造影的灌注缺损和TIC>1021.34 ml面积为独立预测升级因素。
  • 常规影像模型加入超声造影特征后AUROC由0.759升至0.861。

核心结论

  • 在乳腺常规影像基础上加入超声造影可提高对粗针穿刺活检证实导管原位癌术后升级为浸润癌的术前预测能力。

研究设计与样本

  • 回顾性研究,纳入138例患者的140个活检证实导管原位癌病灶,按术后病理分为未升级组和升级组,比较常规超声、钼靶、超声造影及临床病理特征,并比较含与不含超声造影特征模型的预测效能。

关键影像表现/征象

  • 超声上肿块样病灶与术后升级相关(P=0.030)。
  • 钼靶上可疑钙化与术后升级相关(P=0.014)。
  • 超声造影上灌注缺损与术后升级相关(P=0.005)。
  • 超声造影上TIC>1021.34 ml面积与术后升级相关(P<0.001)。
  • 超声上病灶大小>20 mm与术后升级相关(P=0.007)。

诊断标准与关键数值

  • 活检高级别导管原位癌为独立预测因素(P=0.004)。
  • 超声病灶大小>20 mm为独立预测因素(P=0.007)。
  • 超声肿块样病灶为独立预测因素(P=0.030)。
  • 钼靶可疑钙化为独立预测因素(P=0.014)。
  • 超声造影灌注缺损为独立预测因素(P=0.005),TIC>1021.34 ml面积为独立预测因素(P<0.001)。

临床应用与阅片要点

  • 术前评估活检证实导管原位癌时,可结合超声造影特征(灌注缺损、TIC>1021.34 ml面积)辅助预测术后升级风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To evaluate the added value of contrast-enhanced ultrasound (CEUS) on top of breast conventional imaging for predicting the upgrading of ductal carcinoma in situ (DCIS) to invasive cancer after surgery.

METHODS: This retrospective study enrolled 140 biopsy-proven DCIS lesions in 138 patients and divided them into two groups based on postoperative histopathology: non-upgrade and upgrade groups. Conventional ultrasound (US), mammography (MMG), CEUS and clinicopathological (CL) features were reviewed and compared between the two groups. The predictive performance of different models (with and without CEUS features) for histologic upgrade were compared to calculate the added value of CEUS.

RESULTS: Fifty-nine (42.1 %) lesions were histologically upgraded to invasive cancer after surgery. By logistic regression analyses, we found that high-grade DCIS at biopsy (P=0.004), ultrasonographic lesion size > 20 mm (P=0.007), mass-like lesion on US (P=0.030), the presence of suspicious calcification on MMG (P=0.014), the presence of perfusion defect (P=0.005) and the area under TIC>1021.34 ml (P<0.001) on CEUS were six independent factors predicting concomitant invasive components after surgery. The CL+US+MMG model made with the four predictors in the clinicopathologic, US and MMG categories yielded an area under the receiver operating curve (AUROC) value of 0.759 (95 % CI: 0.680-0.828) in predicting histological upgrade. The combination model built by adding the two CEUS predictors to the CL+US+MMG model showed higher predictive efficacy than the CL+US+MMG model (P=0.018), as the AUROC value was improved to 0.861 (95 % CI: 0.793-0.914).

CONCLUSIONS: The addition of contrast-enhanced ultrasound to breast conventional imaging could improve the preoperative prediction of an upgrade to invasive cancer from CNB -proven DCIS lesions.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Zhu Y, Jia X, Zhan W, et al. Adding contrast-enhanced ultrasound can improve the predictive ability of breast conventional ultrasound and mammography for pathological upgrade of biopsy-confirmed ductal carcinoma in situ. Eur J Radiol. 2024. PMID: 39213762. doi:10.1016/j.ejrad.2024.111687

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。